new england journal of medicine semaglutide NEJM on X: "In an interim analysis a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full ESSENCE trial results A newly approved 7.2-mg dose
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12











.webp)











